219 related articles for article (PubMed ID: 1692981)
1. [The role of PSA in prostatic adenocarcinoma].
Manca GP
Minerva Med; 1990 Apr; 81(4):261-4. PubMed ID: 1692981
[TBL] [Abstract][Full Text] [Related]
2. Tumour markers in monitoring the treatment of advanced prostate cancer.
Cooper EH; Armitage TG
Prog Clin Biol Res; 1990; 359():65-72; discussion 73-4. PubMed ID: 1704634
[No Abstract] [Full Text] [Related]
3. [Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer].
Sakai N; Ogawa T; Ishibashi Y; Fukuoka H; Sakanishi S
Hinyokika Kiyo; 1991 Jun; 37(6):589-94. PubMed ID: 1716409
[TBL] [Abstract][Full Text] [Related]
4. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
[TBL] [Abstract][Full Text] [Related]
5. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].
Morote Robles J; de Torres Mateos JA
Arch Esp Urol; 1989; 42 Suppl 2():124-30. PubMed ID: 2484148
[TBL] [Abstract][Full Text] [Related]
6. Prostate specific antigen and prostatic acid phosphatase measurements for the follow-up of patients with prostate cancer.
Mortarelli EA
Ann Clin Lab Sci; 1992; 22(4):201-6. PubMed ID: 1380223
[TBL] [Abstract][Full Text] [Related]
7. Cross-comparison of PSA and PAP values in a wide spectrum of prostate cancer conditions.
Tarle M
Anticancer Res; 1988; 8(4):569-72. PubMed ID: 2460018
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen: a valuable clinical tool.
Oesterling JE
Oncology (Williston Park); 1991 Apr; 5(4):107-22; discussion 122, 125-6, 128. PubMed ID: 1714288
[TBL] [Abstract][Full Text] [Related]
9. [Prostatic specific antigen for detection and monitoring of prostatic cancer].
Gofrit O; Pode D; Gez E; Pfau A; Roizman I; Lifshitz Y; Barak V
Harefuah; 1992 Mar; 122(6):345-8, 408. PubMed ID: 1374729
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of serum markers for prostate cancer.
Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
[TBL] [Abstract][Full Text] [Related]
11. [Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer].
Akimoto S; Akakura K; Masai M; Isaka S; Shimazaki J
Hinyokika Kiyo; 1990 Jul; 36(7):783-91. PubMed ID: 1700588
[TBL] [Abstract][Full Text] [Related]
12. Prostate specific antigen: clinical use in the diagnosis and management of prostate cancer.
Kabalin JN
Geriatrics; 1992 Sep; 47(9):26-32. PubMed ID: 1380941
[TBL] [Abstract][Full Text] [Related]
13. [The clinical use of the prostate-specific antigen in patients with prostatic cancer].
Matveev BP; Sokolov AV; Bukharkin BV; Ledian KM; Tilk AE; Makarova GV
Urol Nefrol (Mosk); 1991; (4):8-12. PubMed ID: 1719686
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of prostatic acid phosphatase and prostate-specific antigen in patients with prostatic cancer.
Pagani F; Zambolin T; Bonora R; Panteghini M
J Nucl Med Allied Sci; 1990; 34(4 Suppl):85-7. PubMed ID: 1709211
[TBL] [Abstract][Full Text] [Related]
16. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
17. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
[TBL] [Abstract][Full Text] [Related]
18. [Tumor markers in prostate cancer].
Kuriyama M
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1915-22. PubMed ID: 7521999
[TBL] [Abstract][Full Text] [Related]
19. Prostate specific antigen in the diagnosis and staging of prostate cancer.
Jung P; Wolff JM; Mattelaer P; Jakse G
Acta Urol Belg; 1996 Sep; 64(3):1-6. PubMed ID: 8946774
[TBL] [Abstract][Full Text] [Related]
20. [Role of prostate-specific antigen in prostatic carcinoma. Validity of an integrated methodologic approach and morpho-biological correlations].
Tomasino RM; Lo Bianco A; Cacciatore M; Pavone C; Carreca I; Morello V; Salvato M; Florena AM; Pavone-Macaluso M
Pathologica; 1989; 81(1072):109-26. PubMed ID: 2475847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
